I wanted to pursue a Master of Biostatistics because I wanted to go into a field that combined my interest in improving health outcomes with my quantitative background as a mathematics major. I also was drawn to this degree due to the ability to collaborate with so many others in biomedical and health-related research in order to solve problems relating to the health and quality of life of individuals and overall populations.

I’ve learned so much from my patients and their different life experiences. An important piece to what we do as PTs is having that opportunity to connect with so many people on a personal level, which is fun.

Before grad school, I spent several years in biomedical research as a laboratory technician, project manager, and clinical trials coordinator. I came to graduate school because I wanted to develop as an independent thinker.

I was working as a hospital pharmacist in Singapore. Our constant struggle, together with other healthcare professionals, with countless unanswered clinical questions in many different medical fields often results in frustration in clinical practice and patient care. My first-hand experience with that struggle inspired and motivated me to contribute to research in the biomedical field.

Broadly, I am interested in understanding how genetic and environmental variation shape phenotypic variation across different timescales.

A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections -- including SARS-CoV-2

I decided to pursue a Master of Biomedical Sciences (MBS) degree to further prepare me for the rigors of a graduate-level curriculum and therefore improve my candidacy for medical school admission.

Congratulations to the 342 students from the Duke University School of Medicine who graduate this month. Despite a historically challenging year, faced with the COVID-19 pandemic and the ongoing impacts of social injustice, students pushed forward with hard work and dedication. We celebrate their many accomplishments and wish them the best in the years ahead.

A new multidisciplinary clinic at Duke plans to provide more seamless treatment for those who have suffered eye strokes.

Duke clinician scientist Anthony Kuo, MD, Associate Professor of Ophthalmology and corneal specialist; and research scientist